West Pharmaceutical Services, Inc.(WST)
NYSE
$396.69
-7.33 (-1.81%)

West Pharmaceutical Services, Inc.(WST)Stock Price & Analysis
NYSE

WST Stock Price Today (November 2026) — West Pharmaceutical Services, Inc. Analysis & Key Metrics 2026-11-19

West Pharmaceutical Services, Inc. (WST) is trading at $396.69, down 1.81% today (as of November 2026).The stock is trading above its 50-day and 200-day moving averages.

  • According to consensus analyst estimates, the 1-year price target is $471.00 (18.7% upside).
  • Volatility is moderate (27.83% annualized), between 25% and 40%.
  • From the latest financial filings: Revenue grew 8.70% in the latest quarter compared with the same quarter a year earlier. Debt is 0.11 times shareholders' equity.

WST Stock Analysis: Key Metrics & Valuation (November 2026)

Key figures from the latest data

Trend posture
Uptrend: above 50- and 200-day averages
Analyst 1Y target$471.00+18.7%
Volatility (30d ann.)27.83%Moderate
RSI (14-day)
47.63 (Neutral)
Debt$313.90M (0.11x D/E)

West Pharmaceutical Services, Inc. - Historical Price & Volume

$396.69
+86.95 (+28.07%)
  • Price
  • Volume
  • Latest price
Range: 2Y

Market Cap

$27.63B

Enterprise Value: $27.48B

P/E Ratio

44.52

Forward P/E: 38.17

Revenue Growth

+8.70%

Latest quarter vs year ago

Analyst Target

$471.00

+18.7% upside potential

Key Investor Questions About WST

What the latest data shows

What do the technicals and fundamentals show for WST?

WST is trading above its 50-day and 200-day moving averages, and its RSI of 47.6 is in the neutral zone (between 30 and 70).

  • Technicals: Neutral (RSI 47.63) (Uptrend: above 50- and 200-day averages)
  • Fundamentals: Revenue +8.7%, debt/equity 0.11x
How fast is WST's revenue growing?

Revenue grew 8.70% in the latest quarter compared with the same quarter a year earlier.

What do WST's risk numbers show?
  • Total debt is $313.90M (0.11 times equity).
  • 30-day volatility is 27.83% annualized, which counts as moderate (between 25% and 40%).

52-Week Trading Range

52-Week Low$223.37
52-Week High$437.99
Current Price$396.69

Over the past year, WST stock traded between $223.37 and $437.99 and currently trades near the high end of that range.

Volatility & Risk Profile

30-Day Volatility27.83%
Beta0.66
RSI (14-day)47.63

30-day volatility is 27.83% annualized, which counts as moderate (between 25% and 40%). Beta 0.66: the stock has moved much less than the market.

Institutional & Insider Ownership

Insider Ownership0.71%
Institutional OwnershipN/A
Shares Short1.81M

Short interest is 3.04% of the float.

Analyst Sentiment & Price Targets

Mean Target
$471.00
Upside Potential
+18.7%
Recommendation
N/A
The mean price target of 15 analysts is $471.00, 18.7% above the current price of $396.69.

Earnings snapshot

No upcoming report date yet

EPS beat rate
92% (11/12)
Avg move after earnings
±12.8%
Options-implied move
—
Options vs history
—
WST earnings history, charts and expected move

Frequently Asked Questions

Common investor questions about West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) is currently trading at $396.69. The RSI (14-day) is 47.6, in the neutral zone (between 30 and 70). The mean analyst price target of $471.00 implies 18.7% upside from current levels. 30-day volatility is 27.83% annualized, which counts as moderate (between 25% and 40%).

Based on current valuation metrics for West Pharmaceutical Services, Inc. (WST): The trailing P/E ratio is 44.52. The forward P/E is 38.17, lower than the trailing P/E, suggesting analysts expect earnings improvement. Price-to-Book is 9.33. Price-to-Sales is 8.14. Different industries trade at different multiples, so these figures are most useful next to Medical Instruments & Supplies peers.

Based on 15 analysts covering WST, the consensus price target is $471.00. This represents a 18.7% upside from the current price of $396.69. The range spans from a low target of $340.00 to a high target of $500.00, reflecting varying levels of optimism among analysts. Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.

Yes, West Pharmaceutical Services, Inc. (WST) pays a dividend with a current yield of approximately 0.26%. The annualized dividend rate is $0.88 per share. The payout ratio is 9.9%, which is conservative and suggests the dividend is well-covered by earnings with room for future increases. The most recent ex-dividend date was Nov 10, 2026.

Key risks for West Pharmaceutical Services, Inc. (WST) shown in the latest data: 1. Moderate volatility (27.8% annualized, between 25% and 40%). 2. Moves in the broader stock market (Beta 0.66: the stock has moved much less than the market).

Here is West Pharmaceutical Services, Inc.'s (WST) current debt and financial health profile: Total debt stands at $313.90M. The debt-to-equity ratio is 0.11x, which is conservative and indicates a strong balance sheet with low leverage. The current ratio is 2.82, indicating strong short-term liquidity. The quick ratio is 1.91. The company holds $464.10M in cash and equivalents. Free cash flow is positive at $453.40M, providing a cushion for debt servicing and shareholder returns.